annual accounts payable:
$3.27M-$229.00K(-6.55%)Summary
- As of today (July 4, 2025), CLDX annual accounts payable is $3.27 million, with the most recent change of -$229.00 thousand (-6.55%) on December 31, 2024.
- During the last 3 years, CLDX annual accounts payable has risen by +$2.04 million (+165.88%).
- CLDX annual accounts payable is now -36.12% below its all-time high of $5.11 million, reached on December 31, 2008.
Performance
CLDX Accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly accounts payable:
$3.41M+$145.00K(+4.44%)Summary
- As of today (July 4, 2025), CLDX quarterly accounts payable is $3.41 million, with the most recent change of +$145.00 thousand (+4.44%) on March 31, 2025.
- Over the past year, CLDX quarterly accounts payable has increased by +$176.00 thousand (+5.44%).
- CLDX quarterly accounts payable is now -33.28% below its all-time high of $5.11 million, reached on December 31, 2008.
Performance
CLDX quarterly accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
CLDX Accounts payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -6.5% | +5.4% |
| 3 y3 years | +165.9% | +234.6% |
| 5 y5 years | +178.1% | +111.9% |
CLDX Accounts payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -6.5% | +165.9% | -10.3% | +287.1% |
| 5 y | 5-year | -6.5% | +211.6% | -10.3% | +500.4% |
| alltime | all time | -36.1% | +1532.5% | -33.3% | +3310.0% |
CLDX Accounts payable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $3.41M(+4.4%) |
| Dec 2024 | $3.27M(-6.6%) | $3.27M(+193.1%) |
| Sep 2024 | - | $1.11M(-70.7%) |
| Jun 2024 | - | $3.80M(+17.6%) |
| Mar 2024 | - | $3.23M(-7.4%) |
| Dec 2023 | $3.49M(+4.6%) | $3.49M(-2.6%) |
| Sep 2023 | - | $3.59M(+307.0%) |
| Jun 2023 | - | $881.00K(-73.9%) |
| Mar 2023 | - | $3.37M(+1.0%) |
| Dec 2022 | $3.34M(+172.0%) | $3.34M(+47.0%) |
| Sep 2022 | - | $2.27M(+151.9%) |
| Jun 2022 | - | $902.00K(-11.5%) |
| Mar 2022 | - | $1.02M(-17.0%) |
| Dec 2021 | $1.23M(+17.2%) | $1.23M(+46.9%) |
| Sep 2021 | - | $836.00K(+22.0%) |
| Jun 2021 | - | $685.00K(-31.3%) |
| Mar 2021 | - | $997.00K(-4.9%) |
| Dec 2020 | $1.05M(-10.7%) | $1.05M(+84.5%) |
| Sep 2020 | - | $568.00K(-40.2%) |
| Jun 2020 | - | $950.00K(-41.0%) |
| Mar 2020 | - | $1.61M(+37.1%) |
| Dec 2019 | $1.17M(+9.8%) | $1.17M(+76.3%) |
| Sep 2019 | - | $666.00K(-34.4%) |
| Jun 2019 | - | $1.02M(-8.1%) |
| Mar 2019 | - | $1.10M(+3.4%) |
| Dec 2018 | $1.07M(-37.7%) | $1.07M(-53.7%) |
| Sep 2018 | - | $2.31M(-21.4%) |
| Jun 2018 | - | $2.94M(+479.1%) |
| Mar 2018 | - | $508.00K(-70.4%) |
| Dec 2017 | $1.72M(-1.4%) | $1.72M(+34.2%) |
| Sep 2017 | - | $1.28M(-35.3%) |
| Jun 2017 | - | $1.98M(-25.8%) |
| Mar 2017 | - | $2.66M(+52.9%) |
| Dec 2016 | $1.74M(+15.5%) | $1.74M(+70.8%) |
| Sep 2016 | - | $1.02M(+44.3%) |
| Jun 2016 | - | $706.00K(-73.2%) |
| Mar 2016 | - | $2.64M(+75.1%) |
| Dec 2015 | $1.51M(-42.1%) | $1.51M(+23.7%) |
| Sep 2015 | - | $1.22M(-39.8%) |
| Jun 2015 | - | $2.02M(-34.2%) |
| Mar 2015 | - | $3.07M(+18.0%) |
| Dec 2014 | $2.60M(+16.0%) | $2.60M(+51.3%) |
| Sep 2014 | - | $1.72M(+44.9%) |
| Jun 2014 | - | $1.19M(-65.2%) |
| Mar 2014 | - | $3.41M(+52.2%) |
| Dec 2013 | $2.24M(+201.1%) | $2.24M(+13.2%) |
| Sep 2013 | - | $1.98M(-4.2%) |
| Jun 2013 | - | $2.07M(-15.6%) |
| Mar 2013 | - | $2.45M(+229.0%) |
| Dec 2012 | $745.00K(-20.3%) | $745.00K(-41.8%) |
| Sep 2012 | - | $1.28M(+224.3%) |
| Jun 2012 | - | $395.00K(-26.2%) |
| Mar 2012 | - | $535.00K(-42.8%) |
| Dec 2011 | $935.00K(+0.4%) | $935.00K(+104.6%) |
| Sep 2011 | - | $457.00K(-11.1%) |
| Jun 2011 | - | $514.00K(-30.4%) |
| Mar 2011 | - | $738.00K(-20.7%) |
| Dec 2010 | $931.00K(-35.6%) | $931.00K(+25.6%) |
| Sep 2010 | - | $741.00K(-30.9%) |
| Jun 2010 | - | $1.07M(-33.6%) |
| Mar 2010 | - | $1.62M(+11.9%) |
| Dec 2009 | $1.45M(-71.7%) | $1.45M(-64.8%) |
| Sep 2009 | - | $4.11M(-5.1%) |
| Jun 2009 | - | $4.33M(-2.8%) |
| Mar 2009 | - | $4.45M(-12.8%) |
| Dec 2008 | $5.11M(+581.6%) | $5.11M(+263.6%) |
| Sep 2008 | - | $1.41M(+5.7%) |
| Jun 2008 | - | $1.33M(-29.3%) |
| Mar 2008 | - | $1.88M(+150.7%) |
| Dec 2007 | $749.90K | $749.90K(-26.7%) |
| Sep 2007 | - | $1.02M(+15.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2007 | - | $887.60K(-12.8%) |
| Mar 2007 | - | $1.02M(-60.1%) |
| Dec 2006 | $2.55M(+123.8%) | $2.55M(+207.1%) |
| Sep 2006 | - | $831.10K(+25.7%) |
| Jun 2006 | - | $661.30K(+10.5%) |
| Mar 2006 | - | $598.50K(-47.5%) |
| Dec 2005 | $1.14M(-34.9%) | $1.14M(+139.2%) |
| Sep 2005 | - | $476.90K(-22.7%) |
| Jun 2005 | - | $617.20K(-45.7%) |
| Mar 2005 | - | $1.14M(-35.2%) |
| Dec 2004 | $1.75M(+268.3%) | $1.75M(+169.4%) |
| Sep 2004 | - | $650.40K(+111.2%) |
| Jun 2004 | - | $307.90K(-27.9%) |
| Mar 2004 | - | $427.30K(-10.2%) |
| Dec 2003 | $475.80K(-43.1%) | $475.80K(+83.6%) |
| Sep 2003 | - | $259.10K(+38.5%) |
| Jun 2003 | - | $187.10K(-46.4%) |
| Mar 2003 | - | $349.00K(-58.3%) |
| Dec 2002 | $836.00K(-26.0%) | $836.00K(+68.3%) |
| Sep 2002 | - | $496.80K(-16.1%) |
| Jun 2002 | - | $592.30K(+129.2%) |
| Mar 2002 | - | $258.40K(-77.1%) |
| Dec 2001 | $1.13M(+25.2%) | $1.13M(+29.4%) |
| Sep 2001 | - | $872.70K(+42.3%) |
| Jun 2001 | - | $613.10K(+60.7%) |
| Mar 2001 | - | $381.60K(-57.7%) |
| Dec 2000 | $902.30K(+56.8%) | $902.30K(+24.9%) |
| Sep 2000 | - | $722.40K(+181.7%) |
| Jun 2000 | - | $256.40K(-29.2%) |
| Mar 2000 | - | $362.40K(-37.0%) |
| Dec 1999 | $575.30K(+43.8%) | $575.30K(+475.3%) |
| Sep 1999 | - | $100.00K(0.0%) |
| Jun 1999 | - | $100.00K(-85.7%) |
| Mar 1999 | - | $700.00K(+75.0%) |
| Dec 1998 | $400.00K(+100.0%) | $400.00K(+100.0%) |
| Sep 1998 | - | $200.00K(-33.3%) |
| Jun 1998 | - | $300.00K(+50.0%) |
| Mar 1998 | - | $200.00K(0.0%) |
| Dec 1997 | $200.00K(-33.3%) | $200.00K(-33.3%) |
| Sep 1997 | - | $300.00K(0.0%) |
| Jun 1997 | - | $300.00K(0.0%) |
| Mar 1997 | - | $300.00K(0.0%) |
| Dec 1996 | $300.00K(-57.1%) | $300.00K(+200.0%) |
| Sep 1996 | - | $100.00K(-50.0%) |
| Jun 1996 | - | $200.00K(0.0%) |
| Mar 1996 | - | $200.00K(-71.4%) |
| Dec 1995 | $700.00K(-12.5%) | $700.00K(-12.5%) |
| Sep 1995 | - | $800.00K(-27.3%) |
| Jun 1995 | - | $1.10M(+37.5%) |
| Mar 1995 | - | $800.00K(0.0%) |
| Dec 1994 | $800.00K(+60.0%) | $800.00K(+33.3%) |
| Sep 1994 | - | $600.00K(-33.3%) |
| Jun 1994 | - | $900.00K(+28.6%) |
| Mar 1994 | - | $700.00K(+40.0%) |
| Dec 1993 | $500.00K(+25.0%) | $500.00K(-16.7%) |
| Sep 1993 | - | $600.00K(+100.0%) |
| Jun 1993 | - | $300.00K(0.0%) |
| Mar 1993 | - | $300.00K(0.0%) |
| Dec 1992 | $400.00K(+100.0%) | - |
| Oct 1992 | - | $300.00K(+200.0%) |
| Jul 1992 | - | $100.00K(-50.0%) |
| Apr 1992 | - | $200.00K(-50.0%) |
| Apr 1992 | $200.00K(-60.0%) | - |
| Oct 1991 | - | $400.00K(+33.3%) |
| Jul 1991 | - | $300.00K(-40.0%) |
| Apr 1991 | $500.00K(-37.5%) | $500.00K(0.0%) |
| Jan 1991 | - | $500.00K(+25.0%) |
| Oct 1990 | - | $400.00K(-20.0%) |
| Jul 1990 | - | $500.00K(-37.5%) |
| Apr 1990 | $800.00K | $800.00K(+100.0%) |
| Jan 1990 | - | $400.00K |
FAQ
- What is Celldex Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Celldex Therapeutics?
- What is Celldex Therapeutics annual accounts payable year-on-year change?
- What is Celldex Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Celldex Therapeutics?
- What is Celldex Therapeutics quarterly accounts payable year-on-year change?
What is Celldex Therapeutics annual accounts payable?
The current annual accounts payable of CLDX is $3.27M
What is the all time high annual accounts payable for Celldex Therapeutics?
Celldex Therapeutics all-time high annual accounts payable is $5.11M
What is Celldex Therapeutics annual accounts payable year-on-year change?
Over the past year, CLDX annual accounts payable has changed by -$229.00K (-6.55%)
What is Celldex Therapeutics quarterly accounts payable?
The current quarterly accounts payable of CLDX is $3.41M
What is the all time high quarterly accounts payable for Celldex Therapeutics?
Celldex Therapeutics all-time high quarterly accounts payable is $5.11M
What is Celldex Therapeutics quarterly accounts payable year-on-year change?
Over the past year, CLDX quarterly accounts payable has changed by +$176.00K (+5.44%)